Oramed Pharmaceuticals
ORMP
#9090
Rank
ยฃ90.18 M
Marketcap
ยฃ2.26
Share price
4.66%
Change (1 day)
15.23%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : ยฃ6.04 Million

According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ6.04 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ7.91 M-82.51%
2023-12-31ยฃ45.25 M422.15%
2022-12-31ยฃ8.66 M
2021-08-31ยฃ8.34 M-5.08%
2020-08-31ยฃ8.79 M-29.97%
2019-08-31ยฃ12.55 M-0.06%
2018-08-31ยฃ12.56 M-16.49%
2017-08-31ยฃ15.04 M18.77%
2016-08-31ยฃ12.66 M1175.53%
2015-08-31ยฃ0.99 M63.34%
2014-08-31ยฃ0.6 M78.01%
2013-08-31ยฃ0.34 M-64.48%
2012-08-31ยฃ0.96 M159.59%
2011-08-31ยฃ0.37 M-8.38%
2010-08-31ยฃ0.4 M26.46%
2009-08-31ยฃ0.31 M-37.34%
2008-08-31ยฃ0.51 M-27.75%
2007-08-31ยฃ0.7 M121.05%
2006-08-31ยฃ0.31 M1170.87%
2005-08-31ยฃ0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ0.87 B 14,395.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
ยฃ40.14 B 664,499.43%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ49.23 B 814,948.76%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
ยฃ40.28 M 566.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
ยฃ63.95 M 958.73%๐Ÿ‡บ๐Ÿ‡ธ USA